International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting

Zagona-Prizio, Caterina; Yousif, Jenna; Grant, Catriona N.; Mehta, Manan; Rosmarin, David; Silverberg, Nanette B.; Tan, Jerry; Larocca, Cecilia; Shinohara, Michi M.; Mostaghimi, Arash; Kim, Brian; Gulliver, Susanne; Gulliver, Wayne; Siegel, Daniel M.; Pérez-Chada, Lourdes M.; Merola, Joseph F.; Gottlieb, Alice B.; Armstrong, April W.

doi:10.36849/jdd.6974

JDD

2022

DOI: 10.36849/jdd.6974

|View full text |Cite

International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting

Caterina Zagona-Prizio¹,

Jenna Yousif²,

Catriona N. Grant³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting

Zundell,

Woodbury,

Lee

et al. 2023

J Rheumatol

View full text Add to dashboard Cite

The International Dermatology Outcome Measures (IDEOM) organization presented an update on its progress related to patient-centered outcome measures for psoriasis (PsO) and psoriatic arthritis (PsA) at the 2022 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Musculoskeletal (MSK) Symptoms working group presented an update on the development of the IDEOM Musculoskeletal Questionnaire (IDEOM MSK-Q). The IDEOM MSK-Q is a patient-reported outcome measure intended to capture MSK symptoms and describe their intensity and impact on health-related quality of life in patients with psoriatic disease. IDEOM also presented the progress of the integration of the Psoriasis Epidemiology Screening Tool (PEST) and Psoriatic Arthritis Impact of Disease (PsAID) questionnaires into the Epic electronic health record system. This will allow for automated PsA screening and symptom measurement in the hopes of improving disease detection and treat-to-target strategies. The Treatment Satisfaction working group discussed the development of the DermSat-7, a 7-item treatment satisfaction questionnaire specific for dermatological conditions. The DermSat-7 is currently being validated in a multicenter study of patients with PsO.

show abstract

Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting

Zundell,

Woodbury,

Lee

et al. 2023

J Rheumatol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting

Cited by 1 publication

References 0 publications

Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting

Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting

Contact Info

Product

Resources

About